Midline brain hamartomatous lesions in fibrodysplasia ossificans progressiva with ACVR1 mutations
- PMID: 36642816
- DOI: 10.1111/neup.12892
Midline brain hamartomatous lesions in fibrodysplasia ossificans progressiva with ACVR1 mutations
Abstract
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by extensive heterotopic ossification of soft tissue structures leading to severe limitations in movement. FOP is caused by a germline mutation in the activating receptor type IA (ACVR1) gene. Worrisome is the fact that up to a third of diffuse intrinsic pontine gliomas (DIPG) also harbor the same point mutation in ACVR1. Radiological reports of central nervous system (CNS) involvement by FOP have described brainstem masses; however, the literature on the histopathology or pathogenesis of these lesions is scant. Here we present detailed neuropathologic findings of a brainstem mass in a patient with FOP and suggest that the tumor is hamartomatous in nature. This report, along with a literature review of radiographic and laboratory data, offers support for the idea that the ACVR1 mutation may incite CNS proliferation, predominantly in the brainstem, but is probably not an oncologic driver. These lesions may be seen at autopsy and are likely noncontributory to death.
Keywords: ACVR1; brainstem; diffuse intrinsic pontine glioma; fibrodysplasia ossificans progressiva; hamartoma.
© 2023 Japanese Society of Neuropathology.
Similar articles
-
The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.Stem Cell Res Ther. 2016 Aug 17;7(1):115. doi: 10.1186/s13287-016-0372-6. Stem Cell Res Ther. 2016. PMID: 27530160 Free PMC article.
-
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.Bone. 2018 Apr;109:210-217. doi: 10.1016/j.bone.2017.06.011. Epub 2017 Jun 16. Bone. 2018. PMID: 28629737 Free PMC article. Review.
-
ACVR1 Function in Health and Disease.Cells. 2019 Oct 31;8(11):1366. doi: 10.3390/cells8111366. Cells. 2019. PMID: 31683698 Free PMC article. Review.
-
Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases.Bone. 2018 Apr;109:91-100. doi: 10.1016/j.bone.2017.08.001. Epub 2017 Aug 2. Bone. 2018. PMID: 28780023 Free PMC article.
-
Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.J Bone Miner Res. 2022 Nov;37(11):2077-2093. doi: 10.1002/jbmr.4617. Epub 2022 Jul 3. J Bone Miner Res. 2022. PMID: 35637634 Free PMC article.
References
REFERENCES
-
- McKusick V. #135100 FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP. Available from URL: https://www.omim.org/entry/135100. Updated August 19, 2017. [Accessed July 7, 2019].
-
- Shore EM, Feldman GJ, Xu M, Kaplan FS. The genetics of fibrodysplasia ossificans progressive. Clinic Rev Bone Miner Metab 2005; 3: 201-204.
-
- Haupt J, Deichsel A, Stange K et al. ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant. Hum Mol Genet 2014; 23: 5364-5377.
-
- Richards S, Aziz N, Bale S et al. ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-424.
-
- Li MM, Datto M, Duncavage EJ et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: A joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 2017; 19: 4-23.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources